Filing Details

Accession Number:
0001209191-20-060741
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-30 16:42:18
Reporting Period:
2020-11-27
Accepted Time:
2020-11-30 16:42:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1761612 Bicycle Therapeutics Plc BCYC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1618273 Lee Kalowski C/O Bicycle Therapeutics Plc
B900, Babraham Research Campus
Cambridge X0 CB22 3AT
President And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2020-11-27 530 $1.56 530 No 4 M Direct
Ordinary Shares Disposition 2020-11-27 530 $20.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2020-11-27 530 $0.00 530 $1.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
112,274 2027-07-23 No 4 M Direct
Footnotes
  1. Shares exercised and sold pursuant to a Rule 10b5-1 trading plan.
  2. This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.33582 to GBP 1.00 as of November 27, 2020.
  3. 20% of the shares subject to the option vested on July 24, 2018, 60% of the shares subject to the option will vest each month thereafter in 36 equal monthly installments, and the remaining 20% of the shares subject to the option will vest on the earlier of (i) the fourth anniversary of the grant date and (ii) the date on which the Issuer's board of directors determines that the Issuer has satisfied certain performance vesting milestones, in all cases provided that the Reporting Person remains continuously employed with us through each applicable vesting date.